DrugSpace Symposium 2025

Interdisciplinary Approaches for Novel Drug Candidates

As drug discovery continues to evolve at a rapid pace, collaboration and innovation across disciplines are more important than ever.
Therefore, we are excited to host the fourth BioSolveIT DrugSpace Symposium. The 2025 edition will focus on interdisciplinary interfaces between medicinal and computational chemistry, along with all related methods.
Taking the big picture into account, we are especially proud to welcome experts from both industry and academia, who will present and discuss their most recent research.

The fourth DrugSpace Symposium will take place on September 24–25, 2025.
Sessions are scheduled to begin each day at 3:00 PM (Berlin time, GMT+2).

Secure your free spot at the DrugSpace 2025 Symposium:

Confirmed Speakers

  • Jens Carlsson
    University of Uppsala
  • Pierre Llompart
    Sanofi
  • Christoph Grathwol
    Karlsruhe Institute of Technology (KIT)
  • Zuzanna Kozicka
    Harvard Medical School, Dana-Farber Cancer Institute
  • Michael Ashley Spies
    University of Iowa
  • Frédéric Dreyer
    Prescient Design, Genentech
  • Abdurrahman Olğaç
    Gazi University
  • Tuomo Kalliokoski
    Orion Pharma
  • Andrea Volkamer
    Saarland University, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)
  • Maria Letizia Barreca
    University of Perugia and co-founder of Sibylla Biotech
  • Alexey Zakharov
    National Institutes of Health (NIH)
  • Allison Mason
    AbbVie

Inviting All Drug Discovery Enthusiasts

The BioSolveIT DrugSpaces Symposium aims to be accessible to the global drug discovery and chemistry research community.
In order to do so, the whole event is free-of-charge and everybody is cordially invited to participate. This includes Medchems and Compchems, decision-makers, professionals from the pharmaceutical, crop science, and healthcare sectors, as well as undergraduate and PhD students, and researchers in general.

Most importantly, we extend our sincere thanks in advance to all brilliant speakers and participants for their valuable contributions.

Bridging Science: Connecting the Pieces to Drug Discovery

During DrugSpace 2025, drug discovery will be explored from a wide range of perspectives.
We are honored to host top experts who will share the most recent insights into medicinal and computational chemistry.

During the medchem sessions, we will delve into key areas of small molecule discovery, scaffold extension and manipulation, and state-of-the-art lead optimization. Beyond classical structure-based design campaigns, exciting topics such as targeting protein intermediates and molecular glues will also be addressed.

The compchem talks will cover topics such as the screening of ultra-large compound collections, along with the opportunities they offer and the challenges they present. The cornerstone of structure and binding mode prediction will be examined from multiple perspectives, including its application in various workflows.

No drug discovery symposium would be complete without an update on the latest developments in AI methods and their applications. These sessions will also touch on the growing role of big data processing in accelerating research and decision-making across the field.


In summary, DrugSpace 2025 brings together diverse approaches, disciplines, and innovations, bridging science across domains, scales, and mindsets.

Valuable Disclaimer

Due to frequent requests in recent editions and due to the length of the symposium, we are offering participants the option to receive a certificate of attendance this year.
So if you need a certificate because you would like to count the symposium as working hours or professional training, or if you need it for your graduate school, that’s no problem.

Secure your free spot at the DrugSpace 2025 Symposium: